Aakash Desai, MD, MPH, FASCO (@ADesaiMD) / X

Aakash Desai, MD, MPH, FASCO

9,788 posts

Aakash Desai, MD, MPH, FASCO

@ADesaiMD

Thoracic/Phase 1 Oncologist @ONealCancerUAB, Asst Prof @UABMedicine | Alum @MayoHemeOnc @UConnIM @MDAndersonNews| Co-Host @HemOncFellows 🎙️ @LungCancerRX

Birmingham, AL

Joined June 2019

Pinned
Aakash Desai, MD, MPH, FASCO
@ADesaiMD
Jul 4, 2020
As #oncologytrainees prepare for their first #patientencounter, the #SPIKES protocol is often a good starting point. What advise do you have for #trainees when #deliveringbadnews? @marklewismd @NarjustDumaMD @GlopesMd @mtmdphd @VPrasadMDMPH @DevikaDasMD @MayoHemeOnc #HOFellowLife
Aakash Desai, MD, MPH, FASCO
@ADesaiMD
May 30, 2024
🚨T-1 #ASCO24 @ASCO! 💪🏼 All set to showcase exciting #NSCLC #LCSM research! #ASCOLung24 ⬇️ Current updated management algorithm for NSCLC, with addition of 1️⃣ Periop Pembrolizumab 2️⃣ Adjuvant Alectinib 3️⃣ Osi/Chemo for EGFRm 4️⃣ Ami/Chemo for EGFR Ex20ins 5️⃣ Repotrectenib ROS1
66K
Aakash Desai, MD, MPH, FASCO
@ADesaiMD
Feb 9, 2023
As @HemOncFellows , #bcsm management has become increasingly complex! Below is a #study guide for #MedOnc #MedEd fellows I have been working on : What do you think? 🧐 @IlanaSchlam @PTarantinoMD @OncBrothers @rleonferre 🛑 #WorkinProgress #NotMedicalAdvice 🙏 #InputsWelcome
72K
Aakash Desai, MD, MPH, FASCO
@ADesaiMD
Feb 21, 2023
Excited for @IASLC #TTLC23 #TTLC2023 to hear the latest on 🫁 #LCSM! @HemOncFellows, prepare for the meeting with #studyguide for #NSCLC treatment! ⬇️ #clinicaltrials are imp to consider! #NotMedicalAdvice #InputsWelcome 🙏 @OncoAlert @MayoHemeOnc @MatthewHoMD @OncMedEdCoP
64K
Aakash Desai, MD, MPH, FASCO
@ADesaiMD
May 30, 2023
Thrilled to announce my next adventure as a Thoracic/Phase 1 Medical Oncologist with @ONealCancerUAB! Heartfelt gratitude for the support of my family, colleagues, and mentors. 🙏🏻🙏🏻 Y’all! Let’s connect at @ASCO #ASCO23 to discuss partnerships, collaborations and trials in
37K
Aakash Desai, MD, MPH, FASCO
@ADesaiMD
Dec 5, 2022
🎄🎅 arrived early this year, thanks to @MayoClinic @MayoCancerCare! Honored and grateful to be conferred the rank of “Assistant Professor of #Medicine” @MayoClinic 📜 ! Thank you to all who believed in me! @MayoHemeOnc 🙏🏻🙏🏻
Aakash Desai, MD, MPH, FASCO
@ADesaiMD
May 27, 2022
Replying to @ADesaiMD
Step 1⃣, let's review what we know already! 👇 #algorithm created with @MatthewHoMD giving 🔍into current Rx, credit @NCCN @JackWestMD PDF: bit.ly/3yZIm7P, blue text 👉 hyperlinks to the trials for 💊💉 Hoping this is📖🔖resource for #patients, and #providers @OncoAlert
Aakash Desai, MD, MPH, FASCO
@ADesaiMD
Feb 14, 2023
Are you looking forward to the exciting data being presented @ASCO #GU23! 📈 Prepare yourself 📚 with this study guide on #RCC #renalcellcancer #kidneycancer before #GU23! #InputsWelcome #NotMedicalAdvice @OncoAlert @shilpaonc @neerajaiims @crisbergerot @montypal
41K
Aakash Desai, MD, MPH, FASCO
@ADesaiMD
May 31, 2022
#ASCO22 Small Cell Lung Cancer📰🧵 1⃣st review what we know already! 👇 #algorithm created with @MatthewHoMD for #SCLC Rx, credit: @NCCN @JackWestMD PDF: bit.ly/3GxPCJI, blue text 👉 hyperlinks to trials for💊💉 Another🔖resource for #patients/#providers @OncoAlert
Aakash Desai, MD, MPH, FASCO
@ADesaiMD
May 27, 2022
#ASCO22 Abstracts released today! Let's dig into some #LCSM studies of interest, trying to create 🧵here and 👀 for #pre-@ASCO discussion! @OncBrothers @OncoAlert @StephenVLiu @JackWestMD @n8pennell @FordePatrick @AMansfieldMD @LaurenByersMD, hoping to meet #LCSM experts #IRL!
Aakash Desai, MD, MPH, FASCO
@ADesaiMD
Jun 2, 2024
LAURA Ph 3: Osimertinib vs Placebo #ASCO24 @ASCO ➡️ mPFS: 39.1 vs 5.6 mo (HR 0.16) ‼️ ➡️ 24-mo PFS: 65% vs 13% 📈 ➡️ 81% received osi at progression 💊, Good! ➡️AE discontinuation**: 13% vs 5% ⚠️ Can't wait for @RamalingamMD's presentation today! 🎤 #ASCO24 @OncoAlert Data
28K
Aakash Desai, MD, MPH, FASCO
@ADesaiMD
May 23, 2020
Feeling bad about not being able to travel to #ASCO20? Maybe this will help! Travel in the time of #COVID19! @ASCO x.com/alvinfoo/statu…
Aakash Desai, MD, MPH, FASCO
@ADesaiMD
Aug 29, 2022
#ESMO22 @myESMO is 🔜, so let’s review where we were @ASCO #ASCO22 in #LCSM to prepare ourselves! We (@FawziAbuRous @esinghimd @msalmanfaisal @drRTee) review major “#Lung #Cancer Treatment Advances ⏩ in 2022” in #CancerInvestigation @HemOncFellows @OncoAlert @LUNGevity @IASLC
Aakash Desai, MD, MPH, FASCO
@ADesaiMD
Mar 12, 2024
It’s official 🎉 My first #grant as faculty and PI few months into my first year on faculty! 🙏 Could not have asked for more! @ONealCancerUAB @lcrf_org Thank you to all my mentors and colleagues who brought me here! @HemOncFellows @LungCancerRx @MayoHemeOnc @IMG_Oncologists
Lung Cancer Research Foundation
@lcrf_org
Mar 12, 2024
LCRF has announced 3 research grant awards funded by Daiichi Sankyo and AstraZeneca, focused on further developing the understanding of the proposed mechanism of action of antibody drug conjugates (ADCs). LCRF.org/ADC #LungCancer @ADesaiMD @NSethakorn Carl Gay, MD, PhD
17K
Aakash Desai, MD, MPH, FASCO
@ADesaiMD
Mar 10, 2021
"#Antigen #presentation in #cancer: insights into tumour immunogenicity and immune evasion" @NatureRevCancer go.nature.com/3l36hu8 Jhunjhunwala et al. describe mechanisms of immune evasion by alteration of antigen repertoire presented on tumors @OncoAlert